KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) EBITDA Margin (2016 - 2025)

Historic EBITDA Margin for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to 17.45%.

  • Thermo Fisher Scientific's EBITDA Margin rose 1100.0% to 17.45% in Q3 2025 from the same period last year, while for Sep 2025 it was 17.16%, marking a year-over-year increase of 2300.0%. This contributed to the annual value of 17.11% for FY2024, which is 11100.0% up from last year.
  • As of Q3 2025, Thermo Fisher Scientific's EBITDA Margin stood at 17.45%, which was up 1100.0% from 16.9% recorded in Q2 2025.
  • Over the past 5 years, Thermo Fisher Scientific's EBITDA Margin peaked at 30.78% during Q2 2021, and registered a low of 14.59% during Q2 2023.
  • Moreover, its 5-year median value for EBITDA Margin was 17.34% (2024), whereas its average is 18.94%.
  • In the last 5 years, Thermo Fisher Scientific's EBITDA Margin soared by 162400bps in 2021 and then plummeted by -92800bps in 2023.
  • Over the past 5 years, Thermo Fisher Scientific's EBITDA Margin (Quarter) stood at 23.72% in 2021, then plummeted by -31bps to 16.25% in 2022, then increased by 5bps to 17.03% in 2023, then rose by 4bps to 17.69% in 2024, then fell by -1bps to 17.45% in 2025.
  • Its EBITDA Margin was 17.45% in Q3 2025, compared to 16.9% in Q2 2025 and 16.56% in Q1 2025.